Effects of a hydroxylated metabolite of the β-adrenoreceptor antagonist, carvedilol, on post-ischaemic splanchnic tissue injury

British Journal of Pharmacology

Volumn 123, Issue 2, 1998, Pages 292-298

  Christopher, Theodore A ^a   Lopez, Bernard L ^a   Ma, Xin Liang ^a,c   Feuerstein, Giora Z ^b   Ruffolo Jr, Robert R ^b   Yue, Tian Li ^b  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b SmithKline Beecham Pharmaceutical ^*  (United States)

^c THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

Antioxidant; Endothelium; Leukocytes; Reactive oxygen species

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARVEDILOL; MYELOPEROXIDASE; REACTIVE OXYGEN METABOLITE; SB 211475; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; HEMATOCRIT; ISCHEMIA; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; REPERFUSION INJURY; SPLANCHNIC BLOOD FLOW; TISSUE INJURY;

ADRENERGIC BETA-ANTAGONISTS; ANIMALS; ANTIOXIDANTS; BLOOD PRESSURE; CARBAZOLES; ENDOTHELIUM, VASCULAR; ISCHEMIA; MALE; MESENTERIC ARTERY, SUPERIOR; MUSCLE RELAXATION; MUSCLE, SMOOTH, VASCULAR; PEROXIDASE; PROPANOLAMINES; RATS; RATS, SPRAGUE-DAWLEY; REPERFUSION INJURY;

EID: 0031964906     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0701598     Document Type: Article

References (24)

1. BECKMAN, J.S. (1994). Peroxynitrile versus hydroxyl radical: The role of nitric oxide in superoxide-dependent cerebral injury. Ann. New York Acad. Sci., 738, 69-75.
2. BOLLI, R. (1991). Oxygen-derived tree radicals and myocardial reperfusion injury: an overview. Cardiovasc. Drug Ther., 5, 249-268.
3. BRADLEY, P.P., PRIEBAT, D.A., CHRISTENSEN, R.D. & ROTHSTEIN, G. (1982). Measurement of cutaneous inflammation: estimation of neutrophil content with an enzyme marker. J. Invest. Dermatol., 78, 206-209.
4. CHAMULITRAT, W., SKREPNIK, N.V. & SPITZER, J.J. (1996). Endotoxin-induced oxidative stress in the rat small intestine: role of nitric oxide. Shock, 5, 217-222.
5. CHRISTOPHER, T.A., LOPEZ, B.L., YUE, T.L., FEUERSTEIN, G.Z. RUFFOLO, Jr. R.R. & MA, X.L. (1995). Carvedilol, a new beta-adrenoceptor blocker, vasodilator and free-radical scavenger, exerts an anti-shock and endothelial protective ettect in rat splanchnic ischemia and reperfusion. J. Pharmacol. Exp. Ther., 273, 64-71.
6. FEUERSTEIN, G.Z. & RUFFOLO, R.R. (1996). Carvedilol, a novel vasodilating beta-blocker with the potentail for cardiovascular organ protection. Eur. Heart J., 17, 24-29.
7. GABOURY, J.P., ANDERSON, D.C. & KUBES, P. (1994). Molecular mechanisms involved in superoxide-induced leukocyte-endothelial cell interactions in vivo. Am. J. Physiol., 266, H637-H642.
8. GLENN, T.M. & LEFER, A.M. (1970). Role of lysosomes in the pathogenesis of splanchnic ischemia shock in cats. Circ. Res., 27, 783-797.
9. GRANGER, D.N., RUTILI, G. & MCCORD, J.M. (1981). Superoxide radicals in feline intestinal ischemia. Gastroenterology. 81, 22-29.
10. GRANGER, D.N., HOLLWARTH, M.E. & PARKS, D.A. (1986). Ischemia-reperfusion injury: role of oxygen-derived free radicals. [Review]. Acta Physiol. Scand., Suppl., 549, 47-63.
11. HAGLUND, U. & LUNDGREN, O. (1978). Intestinal ischemia and shock factors. Fedn. Proc., 37, 2729-2733.
12. LASKY, L.A. (1993). P-sclectin: a 'roll' in acute inflammation. Curr. Biol., 3, 680-682.
13. LOPEZ, B.L., CHRISTOPHER, T.A., YUE, T.L., RUFFOLO, R., FEUERSTEIN, G.Z. & MA, X.L. (1995). Carvedilol, a new beta-adrenoceptor blocker antihypertensive drug, protects against free-radical-induced endothelial dysfunction. Pharmacology, 51, 165-173.
14. MA, X.L., LOPEZ, B.L., CHRISTOPHER, T.A., BIRENBAUM, D.S. & VINTEN-JOHANSEN, J. (1996). Exogenous NO inhibits basal NO release from vascular endothelium in vitro and in vivo. Am. J. Physiol., 271, H2045-H2051.
15. MAGGI, E., MARCHESI, E., COVINI, D., NEGRO, C., PERANI, G. & BELLOMO, G. (1996). Protective effects of carvedilol, a vasodilating beta-adrenoceptor blocker, against in vivo low density lipoprotein oxidation in essential hypertension. J. Cardiavasc. Pharmacol., 27, 532-538.
16. MENGE, H. & ROBINSON, J.W. (1979). Early phase of jejunal regeneration after short term ischemia in the rat. Lab. Invest., 40, 25-30.
17. MORGAN, T. (1994). Clinical pharmacokinetics and pharmacodynamics of carvedilol. Clin. Pharmacokinet., 26, 335-346.
18. MULLANE, K.M., KRAEMER, R. & SMITH, B. (1985). Myeloperoxidase activity as a quantitative assessment of neutrophil infiltration into ischemic myocardium. J. Pharmacol. Meth., 14, 157-167.
19. PATEL, K.D., ZIMMERMAN, G.A., PRESCOTT, S.M., MCEVER, R.P. & MCINTYRH, T.M. (1991). Oxygen radicals induce human endothelial cells to express GMP-140 and bind neutrophils. J. Cell Biol. 112, 749-759.
20. RUFFOLO, Jr, R.R., GELLAI, M., HIEBLE, J.P., WILLETTE, R.N. & NICHOLS, A.J. (1990). The pharmacology of carvedilol. Eur. J. Clin. Pharmacol., 38, Suppl 2, S82-S88.
21. WEYRICH, A.S., MA, X.Y., LEFER, D.J., ALBERTINE, K.H. & LEFER, A.M. (1993). In vivo neutralization of P-selectin protects feline heart and endothelium in myocardial ischemia and reperfusion injury. J. Clin. Invest., 91, 2620-2629.
22. XIA, Y. & ZWEIER, J.L. (1997). Measurement of myeloperoxidase in leukocyte-containing tissues. Anal. Biochem., 245, 93-96.
23. YUE, T.L., CHENG, H.Y., LYSKO, P.G., MCKENNA, P.J., FEUERSTEIN, R., GU, J.L., LYSKOKA, DAVIS, L.L. & FEUERSTEIN, G. (1992). Carvedilol, a new vasodilator and beta adrenoceptor antagonist, is an antioxidant and free radical scavenger. J. Pharmacol. Exp. Ther., 263, 92-98.
24. YUE, T.L., MCKENNA, P.J., LYSKO, P.G., GU, J.L., LYSKO, K.A. & RUFFOLO, Jr. R.R. (1994). SB 211475, a metabolite of carvedilol, a novel antihypertensive agent, is a potent antioxidant. Eur. J. Pharmacol., 251, 237-243.